PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4100
0.00 (0.00%)
Apr 22, 2026, 10:15 AM EST
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 68.44 million as of April 22, 2026. Its market cap has increased by 16.70% in one year.
Market Cap
68.44M
Enterprise Value
67.97M
Revenue
17.60M
Ranking
n/a
PE Ratio
253.87
Stock Price
0.41
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 68.44M, an increase of 2,751.66%. That is a compound annual growth rate of 156.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 68.44M | -9.89% |
| Dec 31, 2025 | 75.95M | 19.91% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.26B |
| Extendicare | 2.64B |
| Sienna Senior Living | 2.39B |
| Green Thumb Industries | 2.20B |
| Decibel Cannabis Company | 75.02M |
| Vext Science | 67.78M |
| Rocket Doctor AI | 66.24M |
| BioNxt Solutions | 66.10M |